Informed consent for cancer screening with prostate-specific antigen: How well are men getting the message?
Informed consent for cancer screening with prostate-specific antigen: How well are men getting the message?
复制标题
DOI：
10.2105/ajph.93.5.779
复制
发表时间：
2003-05-01
影响因子：
12.7
通讯作者：
Aga, DW
中科院分区：
文献类型：
--
作者：
Chan, ECY;Vernon, SW;Aga, DW
目标。这项研究调查了非裔美国人和白人对前列腺特异性抗原(PSA)筛查的了解。由于前列腺癌的PSA筛查存在争议，专业组织建议在筛查时征得知情同意。对304名到门诊就诊的男性进行筛查知识和经验的调查。大多数男性并不知道使用PSA进行筛查的关键事实。非洲裔美国人似乎比白人知识更少，但这些差异是由教育水平和前列腺癌筛查经验的差异所调节的。改善前列腺癌筛查知情同意的公共卫生努力应侧重于突出关键事实，并为具有不同正规教育水平和筛查经验的男子制定不同的方法。
Objectives. This study examined knowledge about prostate-specific antigen (PSA) screening among African Americans and Whites. Because PSA screening for prostate cancer is controversial, professional organizations recommend informed consent for screening.Methods. Men (n=304) attending outpatient clinics were surveyed for their knowledge about and experience with screening.Results. Most men did not know the key facts about screening with PSA. African Americans appeared less knowledgeable than Whites, but these differences were mediated by differences in educational level and experience with prostate cancer screening.Conclusions. Public health efforts to improve informed consent for prostate cancer screening should focus on highlighting the key facts and developing different approaches for men at different levels of formal education and prior experience with screening.